Massage Percussion for Passage of Urolithiasis Fragments After Ureteroscopy.

Massage Percussion Therapy for Passage of Urolithiasis Fragments After Ureteroscopy

Flexible ureteroscopy is characterized as first-line therapy for renal stones < 2 cm in size. Stones are commonly treated with dusting or fragmentation techniques which requires passage of stone fragments after surgery. Quoted stone free rate after flexible ureteroscopy is approximately 40-60% with a dusting technique. Residual fragments are often under 1mm in size and can layer in the lower pole of the kidney, complicating spontaneous stone passage. Improving the stone free rate after surgery decreases the need for secondary surgeries and decreases risk of future stone events.

Numerous techniques have been proposed to increase stone passage including positional changes and percussion therapy. To date, there is overall limited data a lack of techniques that can be readily available in the outpatient setting, easily added to scheduled appointments, reproducible results and well tolerated by patients.

Study Overview

• Status: Terminated
• Conditions: Nephrolithiasis
• Intervention / Treatment: Device: Massage Percussion Therapy device

Detailed Description

Researchers in China have developed a proprietary oscillation machine to be used in an outpatient setting. The External Physical Vibration Lithecbole (EPVL) is used to provide vibration after stone fragmentation to facilitate movement of fragments into a more favorable orientation for stone passage. After extracorporeal shockwave lithotripsy and ureteroscopy, use of EPVL after surgery has been shown to increase stone free rate.

Chest percussion for cystic fibrosis patients has been adapted for use after ureteroscopy. After undergoing extracorporeal shockwave lithotripsy, patients are placed in a percussion physiotherapy vest, given diuretics and positioned in Trendelenburg. Imaging obtained before and after percussion demonstrates successful stone movement and increases stone free rates in several different protocols compared to patients who do not receive percussive therapy.

Percussion therapy is clearly effective to improve stone free rates after ureteroscopy and is effective regardless of technique, protocol, or percussive device. However, proposed techniques with EPVL and chest physiotherapy vests can be expensive, cumbersome and require specialty equipment. In addition, proposed equipment in prior studies is not readily available in outpatient clinics.

• Study Type: Interventional
• Enrollment (Actual): 13
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Canada
  • Montréal, Canada
    • University of Montreal

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Any patient after treatment of renal stones with ureteroscopy during which residual stone fragments (less than 2mm by surgeon estimation) is left in the kidney.
• Must be 18 years or older
• Must be able to give consent
• Preoperative abdominal CT

Exclusion Criteria:

• On pharmacologic anticoagulation. Aspirin up to 81mg will be allowed.
• Cannot tolerate flank, prone or Trendelenburg position.
• Cannot tolerate percussion.
• History of acute rib fractures or osteopenia/osteoporosis.
• Any patient who is on a fluid intake restriction.
• Pregnancy
• Untreated UTI
• History of struvite stones
• Requiring a planned secondary stone procedure within 90 days
• If stent must stay in longer than 10 days
• Ureteral stones (without renal stones)

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

4

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control; Patient receives standard postoperative care with no percussion therapy.
Experimental: PACU percussion; Patient receives percussion therapy in the PACU immediately after surgery.	Device: Massage Percussion Therapy device; Using massage percussion postoperatively.
Experimental: Postoperative appointment percussion; Patient receives percussion therapy in the office on the day of follow up.	Device: Massage Percussion Therapy device; Using massage percussion postoperatively.
Experimental: Both PACU and Postop appointment percussion.; Patient receives percussion therapy in the PACU and receives percussion therapy in the office on the day of follow up.	Device: Massage Percussion Therapy device; Using massage percussion postoperatively.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Patients who are able to tolerate and complete the percussion therapy.	If patients can tolerate the percussion therapy in the treatment arms. This is evaluated by patients being able to complete the percussion therapy session and completing pain questionnaires.	Postop day 0-10.
Stone Free Rate.	Patients will have standard postoperative imaging at six weeks, as is standard of care. Presence of stone fragments and fragment size will determine the postoperative stone free rate.	6 weeks after surgery.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
weight of passed stone fragments	PAtients will strain urine to collect stone fragments after surgery until stent removal. The stone fragments will be sent for stone analysis, as is standard of care, during which fragments will be weighed.	6 weeks.
Unplanned return visits.	Follow patients who have unplanned return trips to the ED or the clinic for pain or complications after surgery.	6 weeks.

Collaborators and Investigators

• Sponsor: Vanderbilt University Medical Center
• Investigators: Principal Investigator: Ryan Hsi, VUmc

Study record dates

Study Major Dates

• Study Start (Actual): February 1, 2024
• Primary Completion (Actual): May 15, 2025
• Study Completion (Actual): May 15, 2025

Study Registration Dates

• First Submitted: May 4, 2023
• First Submitted That Met QC Criteria: May 12, 2023
• First Posted (Actual): May 24, 2023

Study Record Updates

• Last Update Posted (Actual): May 29, 2025
• Last Update Submitted That Met QC Criteria: May 22, 2025
• Last Verified: May 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Urogenital Diseases; Male Urogenital Diseases; Calculi; Pathological Conditions, Anatomical; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Kidney Calculi; Nephrolithiasis; Urinary Calculi; Urolithiasis
• Other Study ID Numbers: VUMC01

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No